Bizmopen (Bismuth subsalicylate Chewable Tablets) 262mg

Bizmopen 262mg chewable tablets contain bismuth subsalicylate, an antidiarrheal and antacid medication. Suitable for temporary relief of mild diarrhea and stomach discomfort. Available in 30-tablet packs for convenient use. Ideal for travel and occasional digestive support.

Strength

262mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Pensa Ilac

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bizmopen 262mg chewable tablets are commonly used to provide temporary relief from mild diarrhea, nausea, and stomach upset. The active ingredient, bismuth subsalicylate, helps soothe the stomach lining and reduce digestive discomfort. It may also be used to alleviate symptoms of indigestion and heartburn.

Side Effects

Bizmopen 262mg chewable tablets work by coating the stomach and reducing irritation in the digestive tract. Users may notice a calming effect on the stomach within a short time after taking the medication. Some people report reduced bloating and a more settled stomach after use.

Precautions & Warnings

Keep Bizmopen 262mg chewable tablets in a cool, dry place away from direct sunlight. Store at room temperature and ensure the container is tightly closed when not in use. Keep out of reach of children and pets to prevent accidental ingestion. Do not use if the seal is broken or damaged.

Avoid Interactions

Bizmopen 262mg chewable tablets may interact with certain medications, including blood thinners like warfarin and tetracycline antibiotics. Avoid taking with other salicylate-containing products, such as aspirin, to reduce the risk of excessive salicylate exposure. Consult a healthcare provider if you are on multiple medications.

Frequently Asked Questions

Bismuth subsalicylate is primarily used to relieve mild diarrhea, nausea, and stomach discomfort.

Chew or dissolve the tablet in the mouth before swallowing. Follow the dosage instructions provided on the packaging or by a healthcare professional.

Avoid combining with other salicylate products or blood thinners unless directed by a healthcare provider.

Some users may experience darkening of the stool or tongue, which is usually temporary and harmless.

Consult a healthcare provider before giving Bizmopen to children under 12 years of age.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.